Abstract
Background Informal health care providers are key actors for health care provision in developing countries for poor populations. Thus, in Cameroon, in 2017, there were more than 3,000 Informal Health facilities. In a context of elimination of mother-to-child transmission of HIV, we describe the offer of Prevention of Mother to Child Transmission of HIV (PMTCT) in informal health centers.
Methods This two-phase cross-sectional study was carried out in two cities in Cameroon notably Douala and Ebolowa. The first step was conducted from March 2019 to July 2019 in 110 informal health centers and the second from August 2019 to January 2020 with 183 Health Providers in these informal health centers. Standardized questionnaires were administered. Data collected were entered in kobo Collect software. Descriptive statistics and logistic regression at a level of significance of 5% were used.
Results Of the 110 informal health centers, 109 integrated HIV testing into the antenatal check-up package. Among them, 43% (47/109) reported giving antiretroviral treatment to HIV infected pregnant women, while the remaining referred them to formal HIV care centers. Regarding delivery services, 52% (53/101) of those who offered them referred HIV exposed newborn for further PMTCT care. Knowledge of PMTCT was insufficient among 51% (94/183) of health providers and 90% (165/183) had insufficient PMTCT practices. Health providers with no PMTCT experience were more likely to have insufficient knowledge of PMTCT (aOR= 32.04, 95%CI: 6.29 to 163.10, p<0.001) whereas, those without any formal PMTCT training were more at risk of having insufficient knowledge (aOR= 3.02, 95%CI: 1.06 to 8.64, p=0.03) and insufficient practices (OR= 4.35, 95%CI: 1.44 to 13.09, p=0.009) towards PMTCT.
Conclusion Given their proximity to the populations and the PMTCT activities they conduct most often; particular attention should be paid to PMTCT in informal health centers.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Clinical Protocols
NA
Funding Statement
They authors did not received a specific funding for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the National Ethics Committee of Cameroon (Ethical clearance no; 2019/03/1155/CE/CNERSH/SP)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
The data that support the findings of this study are not openly available because the PhD thesis work from which this data is derived has not yet been defended.
NA
